Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BLVRA | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | MAGED1 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | HNRNPA0 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | NNMT | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | SECISBP2 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | CDC42SE1 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | GPD2 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | RABGAP1L | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | HTR1E | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | MYO1C | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-05 |